Jan 10, 2023 / 06:30PM GMT
Casey Rene Woodring - JPMorgan Chase & Co, Research Division - Research Analyst
Hi. We're going to start the Charles River Labs presentation here now. So anyway, thank you for joining us today. Like I said, we have Charles River here, CEO, Jim Foster. We'll do a company presentation followed by Q&A, where you'll have a chance to ask questions. But for now, I'll turn it over to Jim.
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Thank you. Nice to be here. I have a little bit of laryngitis, but bear with me. So the safe harbor, Reg G and quiet period statements. I'll give you 8 seconds to read those. So we have a portfolio that starts from early discovery all the way through drugs being approved and actually aftermarket approval. I don't really like the term, but we increasingly have become a one-stop shop for our clients who really want to -- everything is about speed. They want to work with as few research partners as possible, and they want us to have expertise to move their drugs forward as quickly as
Charles River Laboratories International Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers